Axonal transport hypothesis moves on to implicate presenilin: Alzheimer research forum live discussion

Journal of Alzheimer's Disease

Volumn 6, Issue 5, 2004, Pages 537-545

  Busciglio, Jorge ^c   Brady, Scott ^e   Takashima, Akihiko ^a   Klein, Peter ^b   Kim, Leo ^b   LaFerla, Frank ^c   Geula, Changiz ^d   Stokely, Martha ^f   Tezapsidis, Nikolaos ^g   Gouras, Gunnar ^h   Strobel, Gabrielle ⁱ   Crutcher, Keith ^j   Forero, Diego ^k  

^a RIKEN   (Japan)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e UNIVERSITY OF ILLINOIS   (United States)

^f UNIVERSITY OF FLORIDA   (United States)

^g Och Spine at New York Presbyterian Hospitals   (United States)

^h Department of Obstetrics Gynecology   (United States)

ⁱ Alzheimer Research Forum   (United States)

^j UNIVERSITY OF CINCINNATI   (United States)

^k UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CYCLIN DEPENDENT KINASE 5; GLYCOGEN SYNTHASE KINASE 3BETA; KINESIN; PHOSPHATASE; PHOSPHOTRANSFERASE; PRESENILIN 1; PROTEIN KINASE; TAU PROTEIN; AMYLOID PRECURSOR PROTEIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 ALPHA; MEMBRANE PROTEIN; PSEN1 PROTEIN, HUMAN;

ALZHEIMER DISEASE; BRAIN NERVE CELL; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; IN VIVO STUDY; NERVE DEGENERATION; NERVE FIBER TRANSPORT; NONHUMAN; NOTE; PATHOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; CONFERENCE PAPER; GENETICS; HUMAN; NERVE FIBER; PHYSIOLOGY; POINT MUTATION; TRANSPORT AT THE CELLULAR LEVEL;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; AXONS; BIOLOGICAL TRANSPORT; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MEMBRANE PROTEINS; POINT MUTATION; PRESENILIN-1;

EID: 21444454231     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2004-6511     Document Type: Note

References (18)

1. G. Morfini, G. Pigino, U. Beffert, J. Busciglio and S.T. Brady, Fast axonal transport misregulation and Alzheimer's disease, Neuromolecular Med 2 (2002), 89-99.
2. Alzheimer Research Forum, Lithium Hinders Aβ Generation, Buffing Up GSK as Drug Target, http://www.alzforum.org/ new/detail.asp?id=817, 22 May 2003.
3. G. Morfini, G. Szebenyi, R. Elluru, N. Ratner and S.T. Brady, Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility, EMBO J 21 (2002), 281-293.
4. D. Cai, J.Y. Leem, J.P. Greenfield, P. Wang, B.S. Kim, R. Wang, K.O. Lopes, S.H. Kim, H. Zheng, P. Greengard, S.S. Sisodia, G. Thinakaran and H. Xu, Presenilin-1 regulates intracellular trafficking and cell surface delivery of beta-amyloid precursor protein, J Biol Chem 278 (2003), 3446-3454.
5. S. Naruse, G. Thinakaran, J.J. Luo, J.W Kusiak, T. Tomita, T. Iwatsubo, X. Qian, D.D. Ginty, D.L. Price, D.R. Borchelt, P.C. Wong and S.S. Sisodia, Effects of PS1 deficiency on membrane protein trafficking in neurons, Neuron 21 (1998), 1213-1221.
6. Alzheimer Research Forum, Yet Another Molecular Partner for Presenilins Identified, http://www.alzforum.org/new/ detail.asp?id=334, 25 November 2001.
7. G. Pigino, G. Morfini, A. Pelsman, M.P. Mattson, S.T. Brady and J. Busciglio, Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport, J Neurosci 23 (2003), 4499-4508.
8. S. Sato, Y. Tatebayashi, T. Akagi, D.H. Chui, M. Murayama, T. Miyasaka, E. Planel, K. Tanemura, X. Sun, T. Hashikawa, K. Yoshioka, K. Ishiguro and A. Takashima, Aberrant tau phosphorylation by glycogen synthase kinase-3β and JNK3 induces oligomeric tau fibrils in COS-7 cells, J Biol Chem 277 (2002), 42060-42065.
9. F. Zhang, C.J. Phiel, L. Spece, N. Gurvich and P.S. Klein, Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3, J Biol Chem 278 (2003), 33067-33077.
10. J. Dai, R.M. Buijs, W. Kamphorst and D.F. Swaab, Impaired axonal transport of cortical neurons in Alzheimer's disease is associated with neuropathological changes, Brain Res 948 (2002), 138-144.
11. M. Hoshi, M. Sato, S. Matsumoto, A. Noguchi, K. Yasutake, N. Yoshida and K. Sato, Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3β, Proc Natl Acad Sci USA 100 (2003), 6370-6375.
12. A. Takashima, M. Murayama, O. Murayama, T. Kohno, T. Honda, K. Yasutake, N. Nihonmatsu, M. Mercken, H. Yamaguchi, S. Sugihara and B. Wolozin, Presenilin 1 associates with glycogen synthase kinase-3β and its substrate tau, Proc Natl Acad Sci USA 95 (1998), 9637-9641.
13. E. A. Grace and J. Busciglio, Aberrant activation of focal adhesion proteins mediates fibrillar amyloid beta-induced neuronal dystrophy, J Neurosci 23 (2003), 493-502.
14. J. Gotz, F. Chen, J. van Dorpe and R.M. Nitsch, Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ42 fibrils, Science 293 (2001), 1491-1495.
15. F. Kamenetz, T. Tomita, H. Hsieh, G. Seabrook, D. Borchelt, T. Iwatsubo, S. Sisodia and R. Malinow, APP processing and synaptic function, Neuron 37 (2003), 925-937.
16. N. Tezapsidis, P.A. Merz, G. Merz and H. Hong, Microtubular interactions of presenilin direct kinesis of Aβ peptide and its precursors, FASEB J 17 (2003), 1322-1324.
17. H. Braak and E. Braak, Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol 82 (1991), 239-259.
18. K. Stamer, R. Vogel, E. Thies, E. Mandelkow and E.M. Mandelkow, Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress, J Cell Biol 156 (2002), 1051-1063.